HCV RNA in blood donors with isolated reactivities by third-generation RIBA

Transfusion

Volumn 40, Issue 7, 2000, Pages 867-870

  Lemaire, J M ^a,b,c,d,e,f   Courouce, A M ^a,b,c,d,e   Defer, C ^a,b,c,d,e   Bouchardeau, F ^a,b,c,d,e   Coste, J ^a,b,c,d,e   Agulles, O ^a,b,c,d,e   Cantaloube, J F ^a,b,c,d,e   Barlet, V ^a,b,c,d,e   Barin, F ^a,b,c,d,e  

^a Viral Hepatitis Study Group of the French Society of Blood Transfusion ^*  (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c National Institute of Blood Transfusion ^*  (France)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^e UNIVERSITÉ DE TOURS   (France)

^f Etablissement de Transfus Sanguine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; SCREENING TEST; SEROCONVERSION; VIREMIA; VIRUS CARRIER; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0033859731     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40070867.x     Document Type: Article

References (24)

1. Confirmation of hepatitis C infection: A comparison of five immunoblot assays
2. A comparative evaluation of the sensitivity of five anti-hepatitis C virus immunoblot assays
3. Indeterminate hepatitis C
4. New immunoblot resolves indeterminate results for antibody to hepatitis C virus
5. Significance of highly positive c22-3 'indeterminate' second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA
6. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, subtype distribution, and risk factors. The Collaborative Study Group
7. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?
8. What are the consequences of indeterminate results in confirmatory tests for antibodies against transmissible viruses? International Forum
9. Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products
10. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
11. HCV genotypes and risk factors for HCV infection in French blood donors
12. Relevance of RIBA-3 supplementary test to HCV PCR positivity and subtypes for HCV confirmation of blood donors
13. Hepatitis C: Progress and problems
14. A pattern of 5-I-I and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors
15. Significance of NS3 and NS5 antigens in screening for HCV antibody
16. Hepatitis C virus RNA positivity among RIBA-3 indeterminates
17. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA
18. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: Comparison of second- and third-generation anti-HCV assays
19. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay
20. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group
21. Distribution of three major hepatitis C virus subtypes in Italy. A multicentre study of 495 patients with chronic hepatitis C
22. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays)
23. Full or partial seroreversion in patients infected by hepatitis C virus
24. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs